|
|
Volumn 115, Issue 4, 2001, Pages 282-285
|
|
Do all patients in primary care who may benefit from eradication of Helicobacter pylori have access to effective care?
a
a
b
b,c
|
|
Author keywords
Epidemiology; Implementation; Long term acid suppression
|
|
Indexed keywords
CIMETIDINE;
FAMOTIDINE;
HISTAMINE H2 RECEPTOR ANTAGONIST;
LANSOPRAZOLE;
NIZATIDINE;
OMEPRAZOLE;
PROTON PUMP INHIBITOR;
RANITIDINE;
ACCESSIBILITY;
DISEASE CONTROL;
HEALTH SERVICES;
ADULT;
AGED;
ARTICLE;
BARIUM MEAL;
CLINICAL EXAMINATION;
CLINICAL PRACTICE;
CONTROLLED STUDY;
DUODENUM ULCER;
DYSPEPSIA;
ENDOSCOPY;
ERADICATION THERAPY;
FEMALE;
GASTRITIS;
GENERAL PRACTICE;
HEALTH CARE ACCESS;
HEALTH CARE QUALITY;
HEARTBURN;
HELICOBACTER PYLORI;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL RECORD;
MEDICAL RESEARCH;
PATIENT CARE;
PEPTIC ULCER;
PRESCRIPTION;
PRIMARY MEDICAL CARE;
PUBLIC HEALTH SERVICE;
STOMACH ACID;
STOMACH ULCER;
UNITED KINGDOM;
WORKER;
|
|
EID: 0034882149
PISSN: 00333506
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.ph.1900779 Document Type: Article |
|
Times cited : (3)
|
|
References (11)
|
